Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
Esteban Chacón-Solano(Universidad Carlos III de Madrid), Marcela Del Río(Instituto de Salud Carlos III)
Cited by 21
Related Papers
Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer‐prone genodermatoses
|British Journal of Dermatology|2019|61